GNOM Stock Global X Genomics & Biotechnology ETF (GNOM, $8.43) RSI Indicator left the overbought zone on June 11, 2025
at Tickeron.com
GNOM's Stochastic Oscillator is staying in overbought zone for 8 days
The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Technical Analysis (Indicators)
Bearish Trend Analysis
The 10-day RSI Indicator for GNOM moved out of overbought territory on June 11, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator moved out of overbought territory. In of the 16 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNOM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
GNOM broke above its upper Bollinger Band on June 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on May 28, 2025. You may want to consider a long position or call options on GNOM as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for GNOM just turned positive on May 19, 2025. Looking at past instances where GNOM's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .
GNOM moved above its 50-day moving average on June 02, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for GNOM crossed bullishly above the 50-day moving average on June 04, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GNOM advanced for three days, in of 273 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 183 cases where GNOM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Advertisement
General Information
Category Health